IMATINIB MESYLATE 100 MG TAB

imatinib mesylate
$0.7940per EA

Strength

100 mg/1

NDC

00832053209

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

IMATINIB MESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA212135

On Market Since

5/17/2024

Pharmacological Classes

Bcr-Abl Tyrosine Kinase Inhibitors
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A4 Inhibitors
Kinase Inhibitor

Price History

1W

0.0%

1M

-4.0%

3M

-7.7%

6M

-10.7%

1Y

-3.5%

3Y

N/A

5Y

N/A

All

+58.7%